Indegene

Indegene Equity

The The Equity of Indegene (INDGN.NS) as of Oct 17, 2026 is 31.39 B INR. In the previous year, The Equity was 26.16 B INR — a change of 20.00% (higher).

Equity

31.39 BINR

YoY

20.00%

Last updated:

In 2026, Indegene's equity was 31.39 B INR, a 20.00% increase from the 26.16 B INR equity in the previous year.

The Indegene Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
-1.05 B INR
Jan 1, 2021
3.25 B INR
Jan 1, 2022
7.64 B INR
Jan 1, 2023
10.64 B INR
Jan 1, 2024
14.29 B INR
Jan 1, 2025
26.16 B INR
Jan 1, 2026
31.39 B INR
The Indegene Equity history
YEAREquityYoY
31.39 BINR+20.00%
26.16 BINR+83.02%
14.29 BINR+34.35%
10.64 BINR+39.25%
7.64 BINR+135.40%
3.25 BINR-410.00%
-1.05 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indegene Stock analysis

What does Indegene do? Indegene Ltd, headquartered in Bangalore, Karnataka, operates in the life sciences sector, providing digital-led commercialization services. The company supports biopharmaceutical, biotech, and medical device firms with drug development, clinical trials, regulatory submissions, pharmacovigilance, and sales marketing. Its Omnichannel Activation solutions optimize digital-first promotion to healthcare professionals, while Enterprise Commercial and Medical Solutions offer integrated digital marketing and regulatory operations for clients. Indegene is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Indegene's Equity

Indegene's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Indegene's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Indegene's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Indegene's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Indegene’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Indegene stock

The Equity of Indegene is 31.39 B INR in 2026.

The Equity of Indegene changed from 26.16 B INR to 31.39 B INR, representing a 20.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Indegene since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Indegene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Indegene

All Key Metrics — Indegene